Skip to main content
NIH funding notice RFA-RM-18-024

Expanding the Human Genome Engineering Repertoire (U01 Clinical Trial Not Allowed)

Closed on October 18, 2018.

Posted
July 25, 2018
Close date
October 18, 2018
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $821,522 in first-year total cost, median $410,761.

Most frequent study sections

  1. Special Emphasis Panel[ZRG1 GGG-B (70)]1
  2. Special Emphasis Panel[ZRG1 GGG-P (70)]1

Most frequent institutions

  1. DUKE UNIVERSITY1
  2. YALE UNIVERSITY1
Competing awards under RFA-RM-18-024 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2019PNA Nanoparticles for Gene Editing In Vivo1U01AI145965-01GLAZER, PETER MLY, DANITH HSALTZMAN, W. MARKYALE UNIVERSITY, CT$421,111ZRG1
2019Epigenome Editing Technologies for Treating Diverse Disease1U01AI146356-01GERSBACH, CHARLES A.DUKE UNIVERSITY, NC$400,411ZRG1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.